🕵️ VYNE Therapeutics Inc. ($VYNE)
SEC insider & ownership activity, last 12 months · CIK 1566044 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Mar 11, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6.0% | 13G | May 15, 2026 | filing ↗ | |
| Wilmot B. Harkey | 6.0% | 13G | May 15, 2026 | filing ↗ | |
| Daniel Mack | 6.0% | 13G | May 15, 2026 | filing ↗ | |
| Zhang Xiaofan | exited | 13G | Jul 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 24, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 24, 2026 | filing ↗ |
| Earnings (2.02) | Jul 24, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 24, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 24, 2026 | filing ↗ |
| Change of control (5.01) | Jul 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 24, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 24, 2026 | filing ↗ |
| Amendments to the Registrant's Code of Ethics (5.05) | Jul 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 21, 2026 | filing ↗ |
| Other events (8.01) | Jul 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 10, 2026 | filing ↗ |
| Other events (8.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 11, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 17, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 17, 2025 | filing ↗ |
| Change of control (5.01) | Dec 17, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 17, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 17, 2025 | filing ↗ |